跳至主要内容
临床试验/NCT01323699
NCT01323699已完成1 期

Increasing Access and Implementation of Behavioral Treatments for Anxiety and Depression in Rural Veterans With Parkinson's Disease

Michael E. DeBakey VA Medical Center2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2011年11月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
20
试验地点
2
主要终点
Hospital Anxiety and Depression Scale and Hamilton Anxiety Scale

研究概览

简要总结

Behavioral Treatments for Anxiety and Depression (BehTA-D) is a research study for anxiety and depression in individuals with Parkinson's disease (PD). The research clinicians try to teach skills that may help participants cope with anxiety and depression in the context of Parkinson's disease. Research clinicians will also discuss ways improve management of Parkinson's symptoms. Other skills taught include how to relax, change thinking, add in meaningful pleasant activity.

详细描述

Components of evidence-based cognitive behavioral therapy (CBT) treatments from current manuals developed for depression and anxiety will be used to construct the 8-week treatment program. The flexibility of modular based treatment allows patients and counselors to personalize interventions and skills for managing anxiety and depressive symptoms. The first treatment session will be in-person. All following sessions will be provided by telephone. Caregivers will have the option of being involved in 2 ways throughout treatment - as a "coach" to facilitate use of new skills by their loved one with PD and as a recipient of stress- management support. The scope of caregiver involvement will vary across patients, based on their preference. Involved caregivers will be given the opportunity to participate in 1 telephone-based stress-management session and 1 follow-up call scheduled individually during the first 4 weeks of treatment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Have a confirmed diagnosis of idiopathic Parkinson's disease
  • Have significant anxiety and/or depressive symptoms as indicated by a score of greater than 4 on the Geriatric Depression Scale -15 or greater than 5 on the Hospital Anxiety and Depression anxiety subscale

排除标准

  • Patients will be excluded if they have cognitive impairment as indicated by the Montreal Cognitive Assessment (MoCA < 23) or if they have a condition that threatens their safety or life including suicidal intent, current psychosis, bipolar, substance abuse or impulse control disorders within the past month.

结局指标

主要结局

Hospital Anxiety and Depression Scale and Hamilton Anxiety Scale

时间窗: Baseline, 3-months and 4-months

Hamilton Depression Scale and Geriatric Depression Scale - 15

时间窗: Baseline, 3-months, and 4-months

次要结局

  • Parkinson's Disease Questionnaire -8(Baseline, 3-months and 4-months)
  • Client Satisfaction Questionnaire(3-months and 4-months)

研究者

申办方类型
Fed
责任方
Principal Investigator
主要研究者

Jessica Calleo

Clinical Psychologist

Michael E. DeBakey VA Medical Center

研究点 (2)

Loading locations...

相似试验